Lastly, we showed that TASLKO and TASLDKO were, as feeble, strongly protected in the pristane-induced SLE model, demonstrating the relevance of SLC15A4-TASL signalling complex for disease development. This evidence concerns the gene SLC15A4 and systemic lupus erythematosus.